81 related articles for article (PubMed ID: 28030635)
21. Pathologic analysis of primary brain tumors.
McComb RD; Burger PC
Neurol Clin; 1985 Nov; 3(4):711-28. PubMed ID: 3001488
[TBL] [Abstract][Full Text] [Related]
22. Malignant potential of pleomorphic xanthoastrocytoma.
Vu TM; Liubinas SV; Gonzales M; Drummond KJ
J Clin Neurosci; 2012 Jan; 19(1):12-20. PubMed ID: 22137880
[TBL] [Abstract][Full Text] [Related]
23. Expression and Prognostic Value of Oct-4 in Astrocytic Brain Tumors.
Krogh Petersen J; Jensen P; Dahl Sørensen M; Winther Kristensen B
PLoS One; 2016; 11(12):e0169129. PubMed ID: 28030635
[TBL] [Abstract][Full Text] [Related]
24. Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: Expression and prognostic value.
Rosager AM; Sørensen MD; Dahlrot RH; Hansen S; Schonberg DL; Rich JN; Lathia JD; Kristensen BW
PLoS One; 2017; 12(8):e0182954. PubMed ID: 28837569
[TBL] [Abstract][Full Text] [Related]
25. PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.
Roodakker KR; Elsir T; Edqvist PD; Hägerstrand D; Carlson J; Lysiak M; Henriksson R; Pontén F; Rosell J; Söderkvist P; Stupp R; Tchougounova E; Nistér M; Malmström A; Smits A
Oncotarget; 2016 Nov; 7(45):72431-72442. PubMed ID: 27626492
[TBL] [Abstract][Full Text] [Related]
26. Expression of Ki-67, topoisomerase IIalpha and c-MYC in astrocytic tumors: correlation with the histopathological grade and proliferative status.
Faria MH; Gonçalves BP; do Patrocínio RM; de Moraes-Filho MO; Rabenhorst SH
Neuropathology; 2006 Dec; 26(6):519-27. PubMed ID: 17203587
[TBL] [Abstract][Full Text] [Related]
27. WT1 Clone 6F-H2 Cytoplasmic Expression Differentiates Astrocytic Tumors from Astrogliosis and Associates with Tumor Grade, Histopathology, IDH1 Status, Apoptotic and Proliferative Indices: A Tissue Microarray Study.
Abd El-Hafez A; Ismail Hany HSED
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2403-2413. PubMed ID: 32856872
[TBL] [Abstract][Full Text] [Related]
28. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
[TBL] [Abstract][Full Text] [Related]
29. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.
Ceccarelli M; Barthel FP; Malta TM; Sabedot TS; Salama SR; Murray BA; Morozova O; Newton Y; Radenbaugh A; Pagnotta SM; Anjum S; Wang J; Manyam G; Zoppoli P; Ling S; Rao AA; Grifford M; Cherniack AD; Zhang H; Poisson L; Carlotti CG; Tirapelli DP; Rao A; Mikkelsen T; Lau CC; Yung WK; Rabadan R; Huse J; Brat DJ; Lehman NL; Barnholtz-Sloan JS; Zheng S; Hess K; Rao G; Meyerson M; Beroukhim R; Cooper L; Akbani R; Wrensch M; Haussler D; Aldape KD; Laird PW; Gutmann DH; ; Noushmehr H; Iavarone A; Verhaak RG
Cell; 2016 Jan; 164(3):550-63. PubMed ID: 26824661
[TBL] [Abstract][Full Text] [Related]
30. miR-21 Is Linked to Glioma Angiogenesis: A Co-Localization Study.
Hermansen SK; Nielsen BS; Aaberg-Jessen C; Kristensen BW
J Histochem Cytochem; 2016 Feb; 64(2):138-48. PubMed ID: 26701969
[TBL] [Abstract][Full Text] [Related]
31. Prognostic role of Oct4, CD44 and c-Myc in radio-chemo-resistant oral cancer patients and their tumourigenic potential in immunodeficient mice.
Sawant S; Gokulan R; Dongre H; Vaidya M; Chaukar D; Prabhash K; Ingle A; Joshi S; Dange P; Joshi S; Singh AK; Makani V; Sharma S; Jeyaram A; Kane S; D'Cruz A
Clin Oral Investig; 2016 Jan; 20(1):43-56. PubMed ID: 25914047
[TBL] [Abstract][Full Text] [Related]
32. Novel approaches for quantifying protein biomarkers in gliomas: benefits and pitfalls.
Dahlrot RH; Sørensen MD; Rosager AM; Hellwege S; Bangsø JA; Rosenberg T; Petterson SA; Klitkou J; Fosmark S; Hansen S; Kristensen BW
CNS Oncol; 2014 Jul; 3(4):287-98. PubMed ID: 25286040
[TBL] [Abstract][Full Text] [Related]
33. Expression of OCT4A: the first step to the next stage of urothelial bladder cancer progression.
Jóźwicki W; Brożyna AA; Siekiera J
Int J Mol Sci; 2014 Sep; 15(9):16069-82. PubMed ID: 25216339
[TBL] [Abstract][Full Text] [Related]
34. Clinical value of CD133 and nestin in patients with glioma: a population-based study.
Dahlrot RH; Hansen S; Jensen SS; Schrøder HD; Hjelmborg J; Kristensen BW
Int J Clin Exp Pathol; 2014; 7(7):3739-51. PubMed ID: 25120750
[TBL] [Abstract][Full Text] [Related]
35. A study of embryonic stem cell-related proteins in human astrocytomas: identification of Nanog as a predictor of survival.
Elsir T; Edqvist PH; Carlson J; Ribom D; Bergqvist M; Ekman S; Popova SN; Alafuzoff I; Ponten F; Nistér M; Smits A
Int J Cancer; 2014 Mar; 134(5):1123-31. PubMed ID: 24037901
[TBL] [Abstract][Full Text] [Related]
36. Expression of the lysosomal-associated membrane protein-1 (LAMP-1) in astrocytomas.
Jensen SS; Aaberg-Jessen C; Christensen KG; Kristensen B
Int J Clin Exp Pathol; 2013; 6(7):1294-305. PubMed ID: 23826410
[TBL] [Abstract][Full Text] [Related]
37. A population-based study of low-grade gliomas and mutated isocitrate dehydrogenase 1 (IDH1).
Dahlrot RH; Kristensen BW; Hjelmborg J; Herrstedt J; Hansen S
J Neurooncol; 2013 Sep; 114(3):309-17. PubMed ID: 23817809
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]